The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Abstract
Please refer to fig 1 for an algorithmic representation of the recommendations, and tables 1–3 for a risk stratification of endoscopic procedures and medical conditions requiring anticoagulant or antiplatelet therapy. Aspirin therapy can be continued for all endoscopic procedures. Figure 1 Guidelines for the management of patients on warfarin or clopidogrel undergoing endoscopic procedures. AF, atrial fibrillation; EMR, endoscopic mucosal resection; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; FNA, fine needle aspiration; INR, international normalised ratio; LMWH, low molecular weight heparin; PEG, percutaneous endoscopic gastroenterostomy; VTE, venous thromboembolism. View this table: Table 1 Risk stratification of endoscopic procedures based on risk of haemorrhage View this table: Table 2 Risk stratification for discontinuation of anticoagulant therapy View this table: Table 3 Risk stratification for discontinuation of clopidogrel ### 1.1 Acute gastro-intestinal haemorrhage Acute gastro-intestinal haemorrhage in patients on anticoagulant or antiplatelet agents is a high-risk situation. The immediate risk to the patient from haemorrhage may outweigh the risk of thrombosis as a result of stopping anticoagulant or antiplatelet therapy. Patients need to be assessed on an individual basis, and it is not possible to give unequivocal guidance to cover all situations. For patients with high-risk conditions on warfarin, then this can be discontinued with or without substitution of heparin depending on the severity of haemorrhage and risk of discontinuing anticoagulant therapy. There is a high risk of acute myocardial infarction or death if clopidogrel is discontinued in patients with coronary stents, particularly early after implantation, but extending up to 1 year after this. Endoscopy should be attempted as soon as safely possible after urgent liaison between the patient’s cardiologist and the consultant specialist undertaking endoscopy. Clopidogrel should not be discontinued without discussion with a cardiologist. If clopidogrel therapy needs to be discontinued in this context, then this should be limited to a maximum of 5 days as the risk of stent thrombosis increases after this interval. (Evidence grade III. Recommendation grade B.) Early therapeutic endoscopic intervention may achieve haemostasis with minimal or no cessation of anticoagulant or antiplatelet therapy, and should be the first aim. (Evidence grade IV. Recommendation grade C.) ### 1.2 Low-risk endoscopic procedures Anticoagulation or antiplatelet therapy should be continued. (Evidence grade IV. Recommendation grade C.) If warfarin is continued then it should be ensured that the international normalised ratio (INR) does not exceed the therapeutic range: (Evidence grade IV. Recommendation grade C.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease
Szekely, P. (1964) · BMJ · doi:10.1136/bmj.1.5392.1209 · Cited by 325
Cited by
Updated guideline on the management of common bile duct stones (CBDS)
Williams, E., Beckingham, I., El Sayed, G., Gurusamy, K., Sturgess, R., Webster, G., & Young, T. (2017) · Gut · doi:10.1136/gutjnl-2016-312317 · Cited by 480
Dumonceau, J.-M., Tringali, A., Blero, D., Devière, J., Laugiers, R., Heresbach, D., & Costamagna, G. (2012) · Endoscopy · doi:10.1055/s-0031-1291633 · Cited by 470
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
Fujimoto, K., Fujishiro, M., Kato, M., Higuchi, K., Iwakiri, R., Sakamoto, C., Uchiyama, S., Kashiwagi, A., Ogawa, H., Murakami, K., et al. (2014) · Digestive Endoscopy · doi:10.1111/den.12183 · Cited by 462
Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
Baron, T. H., Kamath, P. S., & McBane, R. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206531 · Cited by 457
Veitch, A. M., Vanbiervliet, G., Gershlick, A. H., Boustiere, C., Baglin, T. P., Smith, L.-A., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311110 · Cited by 296
Self-citation
Metadata
- Authors
- Veitch, A. M., Baglin, T. P., Gershlick, A. H., Harnden, S. M., Tighe, R., & Cairns, S.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-05-09
- Volume
- 57
- Issue
- 9
- Pages
- 1322-1329
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2100561298
- Cited by
- 217
- References
- 2
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. https://app.cochat.ai/papers/10.1136/gut.2007.142497
- The paper
- Veitch, A. M., Baglin, T. P., Gershlick, A. H., Harnden, S. M., Tighe, R., & Cairns, S. (2008). Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. https://doi.org/10.1136/gut.2007.142497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.